Scimago Journal & Country Rank

Drug Delivery and Translational Research

Country United States  - SIR icon SIR Ranking of United States
32
H Index
Subject Area and CategoryPharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
PublisherSpringer Publishing Company
Publication typeJournals
ISSN21903948, 2190393X
Coverage2011-2020
Scope The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions. Research focused on the following areas of translational drug delivery research will be considered for publication in the journal. Designing and developing novel drug delivery systems, with a focus on their application to disease conditions; Preclinical and clinical data related to drug delivery systems; Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes Short-term and long-term biocompatibility of drug delivery systems, host response; Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering; Image-guided drug therapy, Nanomedicine; Devices for drug delivery and drug/device combination products. In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

Homepage

How to publish in this journal

Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Pharmaceutical Science2012Q1
Pharmaceutical Science2013Q1
Pharmaceutical Science2014Q1
Pharmaceutical Science2015Q1
Pharmaceutical Science2016Q1
Pharmaceutical Science2017Q1
Pharmaceutical Science2018Q1
Pharmaceutical Science2019Q2
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20120.755
20130.596
20140.640
20150.701
20160.976
20170.944
20180.827
20190.627
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20110.000
Cites / Doc. (4 years)20122.625
Cites / Doc. (4 years)20131.857
Cites / Doc. (4 years)20142.146
Cites / Doc. (4 years)20152.429
Cites / Doc. (4 years)20163.065
Cites / Doc. (4 years)20173.484
Cites / Doc. (4 years)20183.256
Cites / Doc. (4 years)20193.173
Cites / Doc. (3 years)20110.000
Cites / Doc. (3 years)20122.625
Cites / Doc. (3 years)20131.857
Cites / Doc. (3 years)20142.146
Cites / Doc. (3 years)20152.289
Cites / Doc. (3 years)20163.223
Cites / Doc. (3 years)20173.519
Cites / Doc. (3 years)20183.337
Cites / Doc. (3 years)20193.000
Cites / Doc. (2 years)20110.000
Cites / Doc. (2 years)20122.625
Cites / Doc. (2 years)20131.857
Cites / Doc. (2 years)20141.744
Cites / Doc. (2 years)20152.378
Cites / Doc. (2 years)20163.284
Cites / Doc. (2 years)20173.581
Cites / Doc. (2 years)20183.098
Cites / Doc. (2 years)20192.737
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20110
Self Cites20125
Self Cites20136
Self Cites20143
Self Cites20154
Self Cites20167
Self Cites201712
Self Cites201840
Self Cites201916
Total Cites20110
Total Cites2012105
Total Cites2013143
Total Cites2014279
Total Cites2015309
Total Cites2016477
Total Cites2017570
Total Cites2018644
Total Cites2019873
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20110
External Cites per document20122.500
External Cites per document20131.779
External Cites per document20142.123
External Cites per document20152.259
External Cites per document20163.176
External Cites per document20173.444
External Cites per document20183.130
External Cites per document20192.945
Cites per document20110.000
Cites per document20122.625
Cites per document20131.857
Cites per document20142.146
Cites per document20152.289
Cites per document20163.223
Cites per document20173.519
Cites per document20183.337
Cites per document20193.000
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
201117.39
201215.38
20138.33
201424.49
201517.65
201623.94
201722.50
201827.92
201929.59
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20110
Non-citable documents20126
Non-citable documents20138
Non-citable documents201415
Non-citable documents201513
Non-citable documents201612
Non-citable documents20179
Non-citable documents20189
Non-citable documents201914
Citable documents20110
Citable documents201240
Citable documents201377
Citable documents2014130
Citable documents2015135
Citable documents2016148
Citable documents2017162
Citable documents2018193
Citable documents2019291
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20110
Uncited documents201212
Uncited documents201330
Uncited documents201453
Uncited documents201541
Uncited documents201635
Uncited documents201736
Uncited documents201835
Uncited documents201953
Cited documents20110
Cited documents201234
Cited documents201355
Cited documents201492
Cited documents2015107
Cited documents2016125
Cited documents2017135
Cited documents2018167
Cited documents2019252
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
Loading comments...

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2020. Data Source: Scopus®